drugset / Trial / NCT00866021

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

NCT00866021 ↗

Phase 4 Completed 68 enrolled Fundacion SEIMC-GESIDA Abbott · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to assess the efficacy of lopinavir/r in monotherapy and peg-interferon plus ribavirin for the control of both HIV and HCV infection respectively after 12 months of active treatment for HCV.

Timeline

Start
2008-02
Primary completion
2012-06
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Lopinavir/ritonavir Unknown — —